PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $34,000 | -5.6% | 11,855 | +0.3% | 0.00% | – |
| Q4 2021 | $36,000 | -66.7% | 11,820 | -23.1% | 0.00% | – |
| Q3 2021 | $108,000 | -8.5% | 15,370 | +19.8% | 0.00% | – |
| Q2 2021 | $118,000 | +11.3% | 12,825 | +18.3% | 0.00% | – |
| Q1 2021 | $106,000 | -99.2% | 10,845 | -91.6% | 0.00% | -100.0% |
| Q4 2017 | $12,796,000 | +52.9% | 129,447 | +85.2% | 0.01% | +66.7% |
| Q3 2017 | $8,368,000 | +426.3% | 69,879 | +34.9% | 0.00% | +200.0% |
| Q4 2016 | $1,590,000 | +411.3% | 51,803 | +1207.5% | 0.00% | – |
| Q4 2015 | $311,000 | -24.3% | 3,962 | -27.4% | 0.00% | – |
| Q3 2015 | $411,000 | -91.8% | 5,459 | -87.3% | 0.00% | -100.0% |
| Q2 2015 | $5,034,000 | -80.6% | 43,121 | -60.8% | 0.00% | -80.0% |
| Q1 2015 | $25,951,000 | +125.6% | 109,910 | +80.8% | 0.01% | +150.0% |
| Q4 2014 | $11,503,000 | +72.4% | 60,778 | +117.3% | 0.00% | +33.3% |
| Q3 2014 | $6,674,000 | +44.6% | 27,975 | -37.3% | 0.00% | +50.0% |
| Q4 2013 | $4,616,000 | +167.7% | 44,589 | +38.7% | 0.00% | +100.0% |
| Q3 2013 | $1,724,000 | – | 32,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |